Author:
Rydén Lars,Norhammar Anna
Reference8 articles.
1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
2. Association of SGLT2 Inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis;McGuire;JAMA Cardiol,2021
3. Are drugs within a class interchangeable?;Furberg;Lancet,1999
4. Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials;Shi;BMJ,2023
5. The action of phlorizin on the excretion of glucose, xylose, sucrose, creatinine and urea by man;Chasis;J Clin Invest,1933